Literature DB >> 16531147

Colon cancer and apoptosis.

Sergio Huerta1, Emily J Goulet, Edward H Livingston.   

Abstract

BACKGROUND: The implementation of new therapeutic options for the management of metastatic colon cancer mandates a revisit to apoptosis and its role in colon cancer tumorigenesis with an emphasis on the mechanisms leading to chemotherapeutic resistance and immune system evasion of colon cancer cells. DATA SOURCES: Literature regarding molecular apoptosis mechanisms and the role of apoptosis in colon cancer progression are reviewed by this article.
CONCLUSION: Programmed cell death has rapidly emerged as a potential target for cancer treatment at various stages of tumor progression. Chemoprevention, immuno-regulation, and metastasis are prospective targets by which apoptotic mechanisms could be utilized in the prevention and management of tumorigenesis. Understanding how defects in the death receptor pathway of apoptosis permit colon cancer cells to escape the immune system would allow for treatment options whereby the body's immune system could again recognize and eliminate unwanted cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16531147     DOI: 10.1016/j.amjsurg.2005.11.009

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  41 in total

Review 1.  Genotypic characteristics of resistant tumors to pre-operative ionizing radiation in rectal cancer.

Authors:  Zeeshan Ramzan; Ammar B Nassri; Sergio Huerta
Journal:  World J Gastrointest Oncol       Date:  2014-07-15

Review 2.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

3.  Enterobacter Strains Might Promote Colon Cancer.

Authors:  Dilşad Yurdakul; Ayten Yazgan-Karataş; Fikrettin Şahin
Journal:  Curr Microbiol       Date:  2015-07-05       Impact factor: 2.188

4.  An ornamental plant targets epigenetic signaling to block cancer stem cell-driven colon carcinogenesis.

Authors:  Ishfaq Ahmed; Badal C Roy; Dharmalingam Subramaniam; Showkat Ahmad Ganie; Deep Kwatra; Dan Dixon; Shrikant Anant; Mohammad Afzal Zargar; Shahid Umar
Journal:  Carcinogenesis       Date:  2016-01-19       Impact factor: 4.944

Review 5.  Molecular signature of nitric oxide on major cancer hallmarks of colorectal carcinoma.

Authors:  Paramita Mandal
Journal:  Inflammopharmacology       Date:  2017-12-30       Impact factor: 4.473

Review 6.  The orexin receptor OX(1)R in colon cancer: a promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs.

Authors:  Marc Laburthe; Thierry Voisin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

7.  Differential control of growth, apoptotic activity and gene expression in human colon cancer cells by extracts derived from medicinal herbs, Rhazya stricta and Zingiber officinale and their combination.

Authors:  Ayman I Elkady; Rania Abd El Hamid Hussein; Osama A Abu-Zinadah
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

8.  TRAIL and triptolide: an effective combination that induces apoptosis in pancreatic cancer cells.

Authors:  Daniel Borja-Cacho; Yumi Yokoyama; Rohit K Chugh; Nameeta R Mujumdar; Vikas Dudeja; Kimberly A Clawson; Rajinder K Dawra; Ashok K Saluja; Selwyn M Vickers
Journal:  J Gastrointest Surg       Date:  2009-12-16       Impact factor: 3.452

9.  Bax protein may influence the invasion of colorectal cancer.

Authors:  Anna Pryczynicz; Mariusz Gryko; Katarzyna Niewiarowska; Dariusz Cepowicz; Marek Ustymowicz; Andrzej Kemona; Katarzyna Guzińska-Ustymowicz
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  BH3-based fusion artificial peptide induces apoptosis and targets human colon cancer.

Authors:  Yongjun Liu; Yunfeng Li; Haijuan Wang; Jing Yu; Hongwei Lin; Dongkui Xu; Yang Wang; Ailing Liang; Xiao Liang; Xueyan Zhang; Ming Fu; Haili Qian; Chen Lin
Journal:  Mol Ther       Date:  2009-04-07       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.